UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.86B |
| 2 |
Prologis
PLD
|
+$1.82B |
| 3 |
Welltower
WELL
|
+$1.61B |
| 4 |
Microsoft
MSFT
|
+$1.53B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Digital Realty Trust
DLR
|
+$822M |
| 2 |
AutoZone
AZO
|
+$481M |
| 3 |
Extra Space Storage
EXR
|
+$300M |
| 4 |
EMBJ
Embraer S.A. ADS
EMBJ
|
+$284M |
| 5 |
Meta Platforms (Facebook)
META
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.15% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.43% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Liberty Media Series A
FWONA
$22.3B
| $1.74M | ﹤0.01% |
22,230
+1,312
| +6% | +$105K |
|
2102
Monarch Casino & Resort
MCRI
$2.14B
| $1.74M | ﹤0.01% |
18,149
-3,438
| -16% | -$327K |
|
2103
Limbach Holdings
LMB
$867M
| $1.73M | ﹤0.01% |
22,183
+165
| +0.7% | +$13.9K |
|
2104
Collegium Pharmaceutical
COLL
$1.14B
| $1.73M | ﹤0.01% |
52,192
-1,300
| -2% | -$55K |
|
2105
Teva Pharmaceuticals
TEVA
$35.9B
| $1.72M | ﹤0.01% |
57,244
+51,590
| +912% | +$1.66M |
|
2106
Coursera
COUR
$1.54B
| $1.72M | ﹤0.01% |
295,548
+23,318
| +9% | +$146K |
|
2107
Ituran Location and Control
ITRN
$1.08B
| $1.72M | ﹤0.01% |
35,070
+1,026
| +3% | +$48.3K |
|
2108
Quantum Computing Inc
QUBT
$1.68B
| $1.72M | ﹤0.01% |
250,461
-100,819
| -29% | -$922K |
|
2109
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.85B
| $1.71M | ﹤0.01% |
12,935
+9,572
| +285% | +$1.31M |
|
2110
Preferred Bank
PFBC
$1.22B
| $1.7M | ﹤0.01% |
18,795
-1,519
| -7% | -$138K |
|
2111
AnaptysBio
ANAB
$1.6B
| $1.7M | ﹤0.01% |
30,727
+219
| +0.7% | +$11.8K |
|
2112
CVR Energy
CVI
$3.36B
| $1.7M | ﹤0.01% |
50,442
-1,211
| -2% | -$31.1K |
|
2113
Live Oak Bancshares
LOB
$1.95B
| $1.69M | ﹤0.01% |
51,175
+1,383
| +3% | +$51K |
|
2114
Cadre Holdings
CDRE
$1.32B
| $1.69M | ﹤0.01% |
55,021
+9,431
| +21% | +$377K |
|
2115
Barclays
BCS
$94.1B
| $1.69M | ﹤0.01% |
79,737
+65,725
| +469% | +$1.6M |
|
2116
Grocery Outlet
GO
$891M
| $1.68M | ﹤0.01% |
239,000
-31,218
| -12% | -$271K |
|
2117
Xtrackers S&P 500 ESG ETF
SNPE
$2.57B
| $1.68M | ﹤0.01% |
28,284
+15,961
| +130% | +$995K |
|
2118
Crown Castle
CCI
$32.7B
| $1.68M | ﹤0.01% |
20,712
+16,240
| +363% | +$1.4M |
|
2119
MediaAlpha
MAX
$710M
| $1.68M | ﹤0.01% |
180,511
+115,426
| +177% | +$1.14M |
|
2120
Pacira BioSciences
PCRX
$1.02B
| $1.67M | ﹤0.01% |
74,070
+605
| +0.8% | +$13.4K |
|
2121
Energy Recovery
ERII
$434M
| $1.67M | ﹤0.01% |
165,708
+6,054
| +4% | +$79.2K |
|
2122
Kodiak Sciences
KOD
$2.59B
| $1.67M | ﹤0.01% |
43,751
+43,558
| +22,569% | +$1.13M |
|
2123
F&G Annuities & Life
FG
$3.93B
| $1.67M | ﹤0.01% |
65,861
-69,656
| -51% | -$1.82M |
|
2124
Iovance Biotherapeutics
IOVA
$2.23B
| $1.66M | ﹤0.01% |
474,099
+4,393
| +0.9% | +$14.1K |
|
2125
Dimensional Global Real Estate ETF
DFGR
$3.87B
| $1.66M | ﹤0.01% |
+62,418
| New | +$1.71M |
|
Similar funds
UBS AM's Q1 2026 Portfolio in Review
As of Q1 2026, UBS AM held 3,871 positions worth $481B, up 1.7% from $473B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
UBS AM deployed $35.5B of net new capital in Q1 2026, opening 584 new positions and adding to 2,429 existing holdings. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 425,161 shares worth $49.8M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Digital Realty Trust, an estimated $822M trimmed.
- UBS AM's largest Q1 2026 buy was JPMorgan BetaBuilders US Equity ETF: 425,161 shares worth $49.8M.
- UBS AM added most to Broadcom in Q1 2026, an estimated $1.86B increase.
- UBS AM's biggest Q1 2026 reduction was Digital Realty Trust, cutting an estimated $822M.
- UBS AM fully exited CyberArk in Q1 2026, selling an estimated $139M.
- UBS AM's ten largest holdings make up 32% of its $481B portfolio in Q1 2026.
- UBS AM opened 584 new positions and closed 64 in Q1 2026.
- UBS AM's portfolio value rose 1.7% quarter-over-quarter to $481B.
Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.